Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 1–1 | Cite as

EMA confirms new restrictions for prostate cancer therapy

News item
  • 34 Downloads

Reference

  1. European Medicines Agency. EMA restricts use of prostate cancer medicine Xofigo. Internet Document : 27 Jul 2018. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/07/news_detail_002996.jsp&mid=WC0b01ac058004d5c1

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations